BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10920987)

  • 1. [Bcl-2/JH gene re-arrangement determined by PCR as a means to detect minimal residual disease in malignant lymphomas].
    Xiang Z; Chen Y; Li C
    Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):290-2. PubMed ID: 10920987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of bcl-2/JH fusion gene in patients with B cell non-Hodgkin's lymphoma by polymerase chain reaction and its clinical implication].
    Feng W; Huang Z
    Zhonghua Xue Ye Xue Za Zhi; 1997 Jul; 18(7):361-3. PubMed ID: 15624333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PCR study of bcl-2 rearrangement in autologous transplantation of peripheral stem cells in follicular non-Hodgkin's lymphoma].
    Ataulfo González F; Armada B; Villegas A; Llorente L; Pérez J; Díaz Mediavilla J; del Potro E; Martínez R; Alvarez A; Espinós D
    Med Clin (Barc); 1997 May; 108(19):730-3. PubMed ID: 9324596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report.
    Ha CS; Cabanillas F; Lee MS; Besa PC; McLaughlin P; Cox JD
    Clin Cancer Res; 1997 Feb; 3(2):215-9. PubMed ID: 9815675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
    Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity.
    Schmitt C; Balogh B; Grundt A; Buchholtz C; Leo A; Benner A; Hensel M; Ho AD; Leo E
    Leuk Res; 2006 Jun; 30(6):745-50. PubMed ID: 16297448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commercial LightCycler-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma.
    Kornacker M; Kornacker B; Schmitt C; Leo E; Ho AD; Hensel M
    Ann Hematol; 2009 Jan; 88(1):43-50. PubMed ID: 18636259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2 gene rearrangement in Jordanian follicular and diffuse large B-cell lymphomas.
    Almasri NM; Al-Alami J; Faza M
    Saudi Med J; 2005 Feb; 26(2):251-5. PubMed ID: 15770300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and quantification of MBR/JH2 t(14;18) BCL-2 gene rearrangement in follicular lymphoma using a combined real-time polymerase chain reaction assay.
    Csernák E; Tóth E; Melegh Z; Schneider T; Rosta A; Szentirmay Z
    Haematologica; 2006 Jun; 91(6):858-9. PubMed ID: 16704964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of residual disease in follicular lymphomas using the PCR technique: importance of clono-specific probes].
    al Saati T; Galoin S; Roda D; Huynh A; Attal M; Delsol G
    Bull Cancer; 1998 Oct; 85(10):847-54. PubMed ID: 9835862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of bcl-2/JH gene rearrangement by semi-nested polymerase chain reaction from fresh tumor samples in patients with laryngeal squamous cell carcinomas].
    Zhang X; Liu S; Tang S; Lin D; Liang C; An H
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Jun; 35(3):185-7. PubMed ID: 12768773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection and diagnostic value of t(14;18) translocation in minimal residual disease of follicular lymphoma].
    Bessenyei B; Urbán L; Takács I; Zeher M; Szegedi G; Semsei I
    Orv Hetil; 2000 Jul; 141(31):1715-9. PubMed ID: 10976195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage I/II follicular lymphoma: spread of bcl-2/IgH+ cells in blood and bone marrow from primary site of disease and possibility of clearance after involved field radiotherapy.
    Pulsoni A; Starza ID; Frattarelli N; Ghia E; Carlotti E; Cavalieri E; Matturro A; Tempera S; Rambaldi A; Foà R
    Br J Haematol; 2007 May; 137(3):216-20. PubMed ID: 17408460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2 molecular analysis in paraffin-embedded biopsies from diffuse large B-cell lymphomas.
    De Brasi C; Narbaitz M; Rodriguez A; Larripa I; Slavutsky I
    Medicina (B Aires); 2000; 60(3):305-10. PubMed ID: 11050805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma.
    Mahé B; Milpied N; Mellerin MP; Moreau P; Morineau N; Vigier M; Harousseau JL
    Bone Marrow Transplant; 2003 Mar; 31(6):467-73. PubMed ID: 12665842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follicular lymphoma: quantitation of minimal residual disease by PCR of the t(14;18) translocation.
    Darby A; Gribben JG
    Methods Mol Med; 2005; 115():315-31. PubMed ID: 15998976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Achieving Bcl-2/IgH negativity in peripheral blood/bone marrow after therapy implies better prognosis for patients with follicular lymphoma].
    Belada D; Smolej L; Stepánková P; Beránek M; Dvoráková D; Bukac J; Malý J
    Vnitr Lek; 2007 Oct; 53(10):1057-63. PubMed ID: 18072430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescent polymerase chain reaction and capillary electrophoresis for IgH rearrangement and minimal residual disease evaluation in multiple myeloma.
    Novella E; Giaretta I; Elice F; Madeo D; Piccin A; Castaman G; Rodeghiero F
    Haematologica; 2002 Nov; 87(11):1157-64. PubMed ID: 12414345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular diagnosis in hematopoietic malignancy].
    Hoshino A; Funato T; Sasaki T
    Rinsho Byori; 1996 Feb; 44(2):120-5. PubMed ID: 8851193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near?
    Schmitt C; Grundt A; Buchholtz C; Scheuer L; Benner A; Hensel M; Ho AD; Leo E
    Leuk Res; 2006 Dec; 30(12):1563-8. PubMed ID: 16530831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.